Researchers at UiO have tested a new device for delivering hormone treatments for mental illness through the nose. This method was found to deliver medicine to the brain with few side effects.
News - Page 18
Studies show the success of the first effective vaccine against Ebola. This means that the outbreak in Guinea can be brought to an end in a couple of months.
Professor Ludvig M. Sollid and his research group found the real cause of coeliac disease. They have now been singled out as one of five world-leading research teams at UiO, and will receive substantial funding for their international work.
Scientists have developed a method for synthesizing liver cells at a fraction of today’s cost.
Nerve fibres, which transmit impulses from neurons, play a key role in the nervous system. Until now, no-one knew how they formed.
Researchers have discovered several new gene variants that influence brain volume. We are yet another step closer to finding the causes of a number of psychological disorders.
Researchers have discovered that patients with type 1 diabetes can regain the ability to produce insulin. They showed that insulin-producing cells can recover outside the body.
We all have a gene than can cause lethal blood clots, but also protect us against cell death during a stroke. This raises a dilemma for scientists.
Pain and chronic fatigue frequently go hand in hand. In such cases it does not help to ask patients to put on their training shoes and start exercising, according to recent research on Sj?gren’s syndrome.
Cheeses like the Norwegian “gammelost” and Roquefort may prevent weakening of bones when you are ill. New findings show that vitamin K2 protects the production of bone tissue during inflammations.
Is your health ruled by wind, bile or phlegm? Immersive work of Theresia Hofer explores Tibetan medicine in a new and exciting way.
Osteoporosis is one of the most common diseases in Norway. Researchers have now discovered that the body alters genes to counteract the disease.
Transplanted stem cells make the hearts of mice more resistant to heart attacks.
What doctors believed to mark nerve cell death may instead show reparable injury in patients with Multiple Sclerosis.
Our cells eat themselves so that we can stay healthy. A detailed understanding of ‘autophagy’, our cells’ waste management system, may be the key to preventing diseases and extending our lives.
Professor John-Arne R?ttingen has chaired a Chatham House working group on global health financing. They recommand that all countries should invest at least 5% of GDP on health and that high income countries should also provide support to countries with inadequate capacity.
It is over 30 years since smallpox was declared to have been eradicated thanks to the smallpox vaccine. How do vaccines protect us against viruses and bacteria? Can we find a vaccine that will last throughout our lives?
Fewer and fewer pupils in Norwegian schools are given the 20-minute meal break recommended by the government.
Women who have undergone obesity surgery call for psychological follow-up. Unforeseen problems require better individual counselling.
Ammonia is very toxic to the brain and new research shows why: the glial cells ability to remove potassium is perturbed.
Not everyone can be infected by HIV. If you have a gene defect, you may be protected.
Researchers from Institute of Health and Society presented results from a long-term research collaboration with Malawian researchers at a dissemination seminar on reproductive health challenges in Malawi.
Researchers from Norway and Burkina Faso presented findings from a three-year interdisciplinary project on unsafe abortion in Burkina Faso, at a conference in November. Health care providers, researchers and policy makers from Burkina Faso discussed women’s social reality and necessary policy responses to the problem of unsafe abortion.
Altogether 48 new genetic variations that increase the risk of multiple sclerosis (MS) have now been identified. This could form the basis for development of more effective treatment for the disease.
Nobody can afford to wait for almost a year for a vaccine once a deadly influenza virus is on its way. The salvation may now have arrived: a vaccine produced in a couple of weeks – and perhaps even completely free of side-effects.